🇺🇸 FDA
Patent

US 11390667

Compositions and methods for the treatment of neuromyelitis optica

granted A61KA61K39/3955A61K45/06

Quick answer

US patent 11390667 (Compositions and methods for the treatment of neuromyelitis optica) held by The Regents of the University of California expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K39/3955, A61K45/06, A61P, A61P1/08